Gentex (GNTX) PT Lowered to $22 at BMO Capital on 2Q Report; 'Oversold Following 2Q Miss, Outlook Remains Strong'
BMO Capital lowered its price target on Gentex (NASDAQ: GNTX) to $22.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
